The latest News Headlines from the Scientific, Research and HighTech world

Články z PhysOrgS.Africa in $208 mln AIDS drug venture with Swiss Lonza

10. 2 2012 (17:24)

South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.